Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
James Webb Space Telescope spies mysterious high-energy radiation in star nursery - 2One perk to marrying Richard Marx later in life? 'We don't have time' for stupid arguments, says Daisy Fuentes.
- 3South America's Memorable Destinations: A Movement Guide
- 4Instructions to Expand Your Advantages from an Open Record Reward
- 5IDF: Staying in West Bank refugee camps will quell lone-wolf terror
- Cyber Monday 2025: Save over 70% on HBO Max with this Prime Video streaming deal
- Without evidence, CDC changes messaging on vaccines and autism
- Must-See Public Parks from Around the Globe
- Vote In favor of Your Favored IT Administration
- The Reduced Portage Horse: An Inheritance Reconsidered for Present day Experience
- 5 Signs Now is the ideal time to Update Your Android Telephone: When to Take the Action
- What to know about Jack Dorsey's new Vine revival, DiVine
- You finally got a doctor's appointment. Here's how to get the most out of it
- Purdue Pharma's deal means money for some victims, end of Purdue company name. Here's what to know
